Ardent Health (ARDT) Earnings Analysis

Ardent Health (ARDT) has no confirmed upcoming earnings date. Last quarter (2026-03-04) it missed with EPS 0.32 USD vs 0.348 USD est (-8%). It has beaten estimates in 3/4 recent quarters (75%). Trailing P/E 10.92.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does ARDT next report earnings?

No confirmed upcoming earnings date is currently scheduled for ARDT. This page updates as the calendar is published.

ARDT earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-040.32 USD0.348 USD-8%Miss
2025-11-120.52 USD0.424 USD+22.6%Beat
2025-02-260.81 USD0.5 USD+62%Beat
2024-08-140.34 USD0.3 USD+13.3%Beat

Beat rate: 3/4 (75%) over reported quarters with consensus data.

ARDT valuation and analyst view

Trailing P/E10.92
Trailing EPS0.95053 USD
Price / book0.84
Dividend yield0.00%
Market cap1.49B
Analyst consensusBuy (8 buy / 3 hold / 1 sell)
Avg price target14.5 USD

Related research pages

Frequently asked questions

When is Ardent Health (ARDT)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for ARDT. This page updates as the calendar is published.

Did ARDT beat earnings last quarter?

In its 2026-03-04 report, ARDT posted EPS of 0.32 USD versus a 0.348 USD estimate — a miss of 8%.

What is ARDT's earnings track record?

Over the last 4 reported quarters with consensus data, ARDT beat estimates 3 times (75%).

What is ARDT's current P/E ratio and EPS?

ARDT trades at a trailing P/E of 10.92 on trailing EPS of 0.9505329494929541 USD.

What do analysts rate ARDT?

Analyst consensus is "Buy" across 12 ratings (0 strong buy, 8 buy, 3 hold, 1 sell, 0 strong sell). Average 12-month price target: 14.5 USD.